Active ingredient: bortezomib
Trade name: Bortezomib
GTIN: 4751022900231
Producer: TOV of Pharm_dey, Latv_ya / Limited Liability Company "PHARMІDEA", Latvia.
ATC/ATX Code: L01X X32
Dosage: 3.5 mg
Morion Code: 437374
of M_zhnarodne naymenuvannya: BORTEZOMIB
Packaging: Powder liofilizovanny for solution for injections
Packing: On 1 bottle z powder in kartonn_y korobts_.
Ingredients: d_yucha of a rechovin: bortezomib1 a bottle to m_stit a bortezom_ba of 3.5 mg; dopom_zhn_ rechovin: man_t (E421); nitrogen.
of the Indication: multiple myeloma. If high-dose therapy and performing stem cell transplantation is contraindicated to patients. This medicine is combined with Melphalanum and Prednisolonum for treatment of patients who did not receive chemotherapy doses earlier; the progressing multiple myeloma. The provided pharmaceutical drug is combined with doxorubicine, dexamethasone or carry out monotherapy. Treatment is appointed after performing stem cell transplantation, receiving the first line of therapy; a multiple myeloma at patients without receiving treatment earlier and for which there is an opportunity to carry out high-dose chemotherapy with the subsequent transplantirovaniye of stem cells. In that case use a combination with dexamethasone and thalidomide; a lymphoma without an opportunity performing transplantation. If before treatment was not carried out, use a combination of a bortezomib to rituximab, cyclophosphamide, doxorubicine and Prednisonum.
of the Contraindication: It is necessary to be careful at the combined treatment with other medicines. For exact determination of compatibility to study instructions of these medicamentous means in detail. It is impossible to apply in diffusion infiltrative pulmonary and pericardiac diseases. If responses of the patient and survey of the doctor confirm emergence of individual intolerance, this medicine should be cancelled.
Quantity in packing: 1
Pharmacological group: Antineoplastichn_ zasob.
Prescription dispensing: Only from receptomas
of Bortezomib of 3.5 mg No. 1 at the low price of ASUSHIT.COM ✈ Delivery of drugs ✴️ Worldwide.
Characteristics | |
Active ingredient | bortezomib |
ATC/ATX code | L01X X32 |
Contraindications | It is necessary to be careful at the combined treatment with other medicines. For exact determination of compatibility to study instructions of these medicamentous means in detail. It is impossible to apply in diffusion infiltrative pulmonary and pericardiac diseases. If responses of the patient and survey of the doctor confirm emergence of individual intolerance, this medicine should be cancelled. |
Dosage | 3.5 mg |
GTIN | 4751022900231 |
Indications | multiple myeloma. If high-dose therapy and performing stem cell transplantation is contraindicated to patients. This medicine is combined with Melphalanum and Prednisolonum for treatment of patients who did not receive chemotherapy doses earlier; the progressing multiple myeloma. The provided pharmaceutical drug is combined with doxorubicine, dexamethasone or carry out monotherapy. Treatment is appointed after performing stem cell transplantation, receiving the first line of therapy; a multiple myeloma at patients without receiving treatment earlier and for which there is an opportunity to carry out high-dose chemotherapy with the subsequent transplantirovaniye of stem cells. In that case use a combination with dexamethasone and thalidomide; a lymphoma without an opportunity performing transplantation. If before treatment was not carried out, use a combination of a bortezomib to rituximab, cyclophosphamide, doxorubicine and Prednisonum. |
International name | BORTEZOMIB |
Morion code | 437374 |
Pharmacological group | Antineoplastichn_ zasob. |
Producer | TOV of Pharm_dey, Latv_ya / Limited Liability Company "PHARMІDEA", Latvia. |
Release form | Powder liofilizovanny for solution for injections |
Structure | d_yucha of a rechovin: bortezomib1 a bottle to m_stit a bortezom_ba of 3.5 mg; dopom_zhn_ rechovin: man_t (E421); nitrogen. |
Trade name | Bortezomib |
Bortezomib 3.5 mg No. 1 powder
- Product Code: 135230
- In Stock
- Ready to ship
-
$358.41
Related Products
Tags: Medicines, Antineoplastic means